FTC settlement with Cephalon over Provigil pay-for-delay claims will send signal to industry, Ramirez says

The following article first appeared on May 28 on MLex. For more information on MLex, including getting access to its exclusive content, please contact sales@mlex.com. The Federal Trade Commission’s $1.2 billion settlement with Cephalon over claims that the company illegally delayed generic versions of its sleep disorder drug Provigil